Track the 澳洋健康 share price and the full directors' dealings record of the company, a listed equity based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 澳洋健康 has recorded 1 insider filings. Market capitalisation: €2.4bn. The latest transaction was reported on 11 April 2023 (Sale). Among the most active insiders: 周晓阳. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
澳洋健康 is a company operating in the health and pharmaceutical sector, listed on the XSHE market. It focuses on the development and distribution of health products.